BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9567268)

  • 1. [Role of angiotensin II as blood pressure regulator and the the development of lesions in hypertension target organs].
    Pose-Reino A; González-Juanatey JR
    Med Clin (Barc); 1998 Mar; 110(9):342-3. PubMed ID: 9567268
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice.
    Hercule HC; Tank J; Plehm R; Wellner M; da Costa Goncalves AC; Gollasch M; Diedrich A; Jordan J; Luft FC; Gross V
    Exp Physiol; 2007 Nov; 92(6):1014-22. PubMed ID: 17644703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac consequences of aldosterone excess in human hypertension.
    Rossi GP
    Am J Hypertens; 2006 Jan; 19(1):10-2. PubMed ID: 16461183
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The "Dieter Klaus Price for Hypertension Research 199". Central angiotensin II is important for blood pressure regulation].
    Böhm M; Schinke M
    Fortschr Med; 1999 Mar; 117(8):47-8. PubMed ID: 10220960
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary flow reserve: a new target for treating hypertension.
    Barrios V; Escobar C; Echarri R
    Hypertens Res; 2009 Apr; 32(4):316; author reply 317. PubMed ID: 19282864
    [No Abstract]   [Full Text] [Related]  

  • 7. [The bioactivity of angiotensin II and the effects of related Chinese Herbs].
    Shen YH; Chen CX
    Zhongguo Zhong Yao Za Zhi; 2003 May; 28(5):394-7, 431. PubMed ID: 15139119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.
    Cruzado MC; Risler NR; Miatello RM; Yao G; Schiffrin EL; Touyz RM
    Am J Hypertens; 2005 Jan; 18(1):81-7. PubMed ID: 15691621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of limbic peptidergic circuits in regulation of arterial pressure, relevant to development of essential hypertension.
    Ku YH
    Neuropeptides; 2006 Oct; 40(5):299-308. PubMed ID: 16790274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is hypertension a disease of the intra-renal renin-angiotensin system?].
    Ménard J
    Bull Acad Natl Med; 2004; 188(4):661-4; discussion 664-5. PubMed ID: 15587685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly developed angiotensin II-infused experimental models in vascular biology.
    Qin Z
    Regul Pept; 2008 Oct; 150(1-3):1-6. PubMed ID: 18562020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further insights into the role of angiotensin II in kidney development.
    Lasaitiene D; Chen Y; Adams MA; Friberg P
    Clin Physiol Funct Imaging; 2006 Jul; 26(4):197-204. PubMed ID: 16836691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
    Duprez DA
    J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulatory mechanisms of cardiovascular remodeling in hypertension].
    Kurabayashi M
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():221-8. PubMed ID: 16895188
    [No Abstract]   [Full Text] [Related]  

  • 16. RGS2: a "turn-off" in hypertension.
    Le TH; Coffman TM
    J Clin Invest; 2003 Feb; 111(4):441-3. PubMed ID: 12588881
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
    Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM
    J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats.
    Kirimura K; Takai S; Jin D; Muramatsu M; Kishi K; Yoshikawa K; Nakabayashi M; Mino Y; Miyazaki M
    Hypertens Res; 2005 May; 28(5):457-64. PubMed ID: 16156510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney.
    Hall JE; Brands MW; Henegar JR
    J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S258-65. PubMed ID: 10201880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.